Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria (Q21143739)
Jump to navigation
Jump to search
scientific article
- Chlorproguanil−Dapsone−Artesunate versus Artemether−Lumefantrine: A Randomized, Double-Blind Phase III Trial in African Children and Adolescents with Uncomplicated Plasmodium falciparum Malaria
Language | Label | Description | Also known as |
---|---|---|---|
English | Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria |
scientific article |
|
Statements
Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malaria (English)
0 references
Steffen Borrmann
Steffen
Borrmann
Seth Owusu-Agyei
1 reference
Brian Greenwood
Brian
Greenwood
Akintunde Sowunmi
Akintunde
Sowunmi
Peter A
Winstanley
Peter A Winstanley
Rich E Umeh
Fabian Esamai
Emmanuel U Ezedinachi
Stephen Oguche
Stephan Duparc
Paula L Kirby
Allan Pamba
Lynda Kellam
Robert Guiguemdé
Stephen A Ward
2009
0 references
4
0 references
8
0 references
e6682
0 references
19 August 2009
1 reference
1 reference
1 reference
1 reference